David Holmes. Show Affiliations »
Abstract
Mesh: See more » Cost-Benefit AnalysisDrug ApprovalHumansQuality-Adjusted Life YearsState MedicineUnited Kingdom
Year: 2013 PMID: 23467219 DOI: 10.1038/nm0313-248
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 53.440